Altshuler Shaham LTD Amphastar Pharmaceuticals, Inc. Transaction History

Altshuler Shaham LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$45.51 - $65.0 $20,069 - $28,665	441 New	441 $20,000
Q2 2022 Aug 10, 2022	SELL	$29.79 - $42.29 $34,824 - $49,437	-1,169 Reduced 41.51%	1,647 $57,000
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $12,605 - $20,011	549 Added 24.22%	2,816 $101,000
Q4 2021 Feb 15, 2022	BUY	$18.14 - $23.29 $41,123 - $52,798	2,267 New	2,267 $53,000
Q2 2019 Aug 06, 2019	SELL	$18.92 - $22.96 $6,243 - $7,576	-330 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$19.46 - $25.28 $6,421 - $8,342	330 New	330 $7,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.